• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Esophageal Pre-Cancer Testing Gaining Greater Traction

Esophageal Pre-Cancer Testing Gaining Greater Traction

by Ron Shinkman | Oct 29, 2024 | Clinical Diagnostics Insider, FDA-dtet

How three companies are addressing screening challenges with tests that help improve chances of early detection

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Recent FDA Approvals Aim to Make HPV Testing for Women More Accessible

Diagnostics Pipeline: Recent FDA Approvals Aim to Make HPV Testing for Women More Accessible

by Ron Shinkman | Sep 25, 2024 | Clinical Diagnostics Insider, FDA-dtet

Expansion of use for two assays gives patients the option to self-collect specimens at home and in the clinic, which may help address gaps in screening

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Removing Restrictions to Germline Testing

Removing Restrictions to Germline Testing

by Oscelle Boye, MBiomed | Sep 23, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet

With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
PGx Testing: First, Do No Harm

PGx Testing: First, Do No Harm

by Michael Schubert, PhD | Sep 20, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Demand for Digital Pathology

The Demand for Digital Pathology

by Michael Schubert, PhD | Sep 19, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

When it comes to cancer, patients’ greatest fear is diagnostic delays—and they believe digital pathology and AI can reduce those delays

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com